Rankings
▼
Calendar
XENE Q2 2025 Earnings — Xenon Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena
XENE
Xenon Pharmaceuticals Inc.
$5B
Q2 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$632,000
Operating Income
-$94M
Net Income
-$85M
EPS (Diluted)
$-1.07
QoQ Revenue Growth
-100.0%
Cash Flow
Operating Cash Flow
-$64M
Free Cash Flow
-$64M
Stock-Based Comp.
$14M
Balance Sheet
Total Assets
$674M
Total Liabilities
$40M
Stockholders' Equity
$634M
Cash & Equivalents
$135M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$632,000
$0
—
Operating Income
-$94M
-$69M
-36.4%
Net Income
-$85M
-$58M
-46.2%
← FY 2025
All Quarters
Q3 2025 →